Chromogranin A
Chromogranin A is a protein released from neuroendocrine cells and is used as a biomarker to detect and monitor neuroendocrine tumors.
Chromogranin A is a key biomarker for diagnosing and monitoring neuroendocrine tumors.
Key facts at a glance
- Units
- ng/mL
- Clinical utility
- diagnostic
- Result kind
- quantitative
- FDA-cleared
- Roche Chromogranin A, Abbott Chromogranin A, CIS Bio CgA
Chromogranin A (CgA) is a protein found in the secretory granules of neuroendocrine cells. It is released into the bloodstream along with hormones and other substances.
Elevated levels of CgA in the blood can indicate the presence of neuroendocrine tumors, which are tumors that arise from cells of the endocrine and nervous systems.
The test is often used in conjunction with other diagnostic tools to confirm the diagnosis and to monitor the effectiveness of treatment.
Frequently asked questions
What conditions can cause elevated Chromogranin A levels?
How is the Chromogranin A test performed?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy